The system will be going down for regular maintenance at 6pm NZT today for approximately 15minutes. Please save your work and logout.
Loss of heterozygosity of the H4833Y mutation on RYR1 gene causing malignant hyperthermia : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Genetics at Massey University, Palmerston North
Malignant hyperthermia is a potentially fatal pharmacological disorder and is
triggered by volatile anaesthetics in predisposed individuals. Mutations in the
RYR1 gene, encoding the skeletal muscle calcium receptor channel have been
linked to MH susceptibility. Over 200 point mutations have been have been found
to date in the RYR1 gene linked to MHS worldwide.
EBV-immortalization is regularly used worldwide as an effective procedure for
inducing long-term growth of human B lymphocytes. In the current study, it was
observed that immortalized lymphocytes from MHS patients heterozygous for the
missense mutation H4833Y when initially cultured expressed both wild type and
mutant allele but after a few weeks of culture they seemed to lose the mutant
allele. High resolution melting assays and hybridization probe assays showed the
loss of heterozygosity and this was confirmed using DNA sequencing.
Genotyping and haplotype analysis using three intragenic RFLPs and two (CA)n
repeat microsatellite markers tightly linked to the RYR1 gene showed a definite
change in the haplotype, suggesting more widespread changes in the genome
upon short-term culture of EBV-immortalized B-lymphocytes